SEARCH

SEARCH BY CITATION

References

  • Arnsten, A.F., Cai, J.X., Murphy, B.L. & Goldman-Rakic, P.S. (1994) Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116, 143151.
  • Asghari, V., Sanyal, S., Buchwaldt, S., Paterson, A., Jovanovic, V. & Van Tol, H.H.M. (1995) Modulation of intracellular cyclic AMP levels by different human dopamine receptor variants. J Neurochem 65, 11571165.
  • Baldelli, P., Novara, M., Carabelli, V., Hernandez-Guijo, J.M. & Carbone, E. (2002) BDNF up-regulates evoked GABAergic transmission in developing hippocampus by potentiating presynaptic N- and P/Q-type Ca2+ channels signalling. Eur J Neurosci 16, 22972310.
  • Barkley, R.A. (1997) Behavioral inhibition, sustained attention and executive functions: constructing a theory of ADHD. Psychol Bull 121, 6594.
  • Bartres-Faz, D., Junque, C., Serra-Grabulosa, J.M., Lopez-Alomar, A., Moya, A., Bargallo, N., Mercader, J.M., Moral, P. & Clemente, I.C. (2002) Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects. Neuroreport 13, 11211125.
  • Bates, J.A., Goldman, D. & Malhotra, A.K. (2003) COMT and neurocognition: new evidence for a Role in visual memory. Schiz Res 60, S123.
  • Bearden, C.E., Jawad, A.F., Lynch, D.R., Sokol, S., Kanes, S.J., McDonald-McGinn, D.M., Saitta, S.C., Moss, E., Wang, P.P., Zackai, E., Emanuel, B.S. & Simon, T.J. (2004) Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry 161, 17001702.
  • Bellgrove, M.A., Domschke, K., Hawi, Z., Kirley, A., Mullins, C., Roberts, I.H. & Gill, M. (2005) The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD. Exp Brain Res 163, 352360.
  • Benton, A.L. (1994) Neuropsychological assessment. Annu Rev Psychol 45, 123.
  • Berman, S.M. & Noble, E.P. (1995) Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele. Behav Genet 25, 4558.
  • Bertolino, A., Caforio, G., Blasi, G., De Candia, M., Latorre, V., Petruzzella, V., Altamura, M., Nappi, G., Papa, S., Callicott, J.H., Mattay, V.S., Bellomo, A., Scarabino, T., Weinberger, D.R. & Nardini, M. (2004) Interaction of COMT Val108/158Met genotype and olanzapine treatment in prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 161, 17981805.
  • Bilder, R.M., Volavka, J., Czobor, P., Malhotra, A.K., Kennedy, J.L., Ni, X., Golman, R.S., Hptman, M.J., Sheitman, B., Lindenmayer, J.P., Citrome, L., McEvoy, J.P., Kunz, M., Chakos, M., Cooper, T.B. & Lieberman, J.A. (2002) Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia. Biol Psychiatry 52, 701707.
  • Bilder, R.M., Volavka, J., Lachman, H.M. & Grace, A.A. (2004) The catechol-o-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29, 19431961.
  • Bouchard, T.J. Jr (1998) Genetic and environmental influences on adult intelligence and special mental abilities. Hum Biol 70, 257279.
  • Brozoski, T., Brown, R.M., Rosvold, H.E. & Goldman, P.S. (1979) Cognitive deficit caused by regional depletion of dopamine in the prefrontal cortex of rhesus monkeys. Science 205, 929932.
  • Castner, S.A., Williams, G.V. & Goldman-Rakic, P.S. (2000) Reversal of antipsychotic-induced working memory deficits by short-term D1 receptor stimulation. Science 287, 20202022.
  • Celada, P., Siuciak, J.A., Tran, T.M., Altar, C.A. & Tepper, J.M. (1996) Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphe serotonergic neurons. Brain Res 712, 293298.
  • Constantinidis, C., Williams, G.V. & Goldman-Rakic, P.S. (2002) A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci 5, 175180.
  • Cools, R. & Robbins, T.W. (2004) Chemistry of the adaptive mind. Philos Transact A Math Phys Eng Sci 362, 28712888.
  • Cools, R., Barker, R.A., Sahakian, B.J. & Robbins, T.W. (2001) Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 11, 11361143.
  • Cools, R., Stefanova, E., Barker, R.A., Robbins, T.W., Owen, A.M. (2002) Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125, 584594.
  • Damasio, A.R. (1994) Descartes' Error. Emotion, Reason and the Human Brain. Putnam, New York.
  • Davidson, R.J., Pizzagalli, D., Nitschke, J.B. & Putnam, K. (2002) Depression: perspectives from affective neuroscience. Annu Rev Psychol 53, 545574.
  • Dempster, E., Toulopoulou, T., McDonald, C., Bramon, E., Walshe, M., Filbey, F., Wickham, H., Sham, P.C., Murray, R.M. & Collier, D.A. (2005) Association between BDNF val (66) met genotype and episodic memory. Am J Med Genet 134B, 7375.
  • Deutch, A.Y. & Roth, R.H. (1999) Neurotransmitters. In Zigmond, M.J., Bloom, F.E., Landis, S.C., Roberts, J.L. & Squire, L.R. (eds), Fundamental Neuroscience. Academic Press, San Diego, pp. 193234.
  • Diamond, A., Briand, L., Fossella, J. & Gehlbach, L. (2004) Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 161, 125132.
  • DiMaio, S., Grizenko, N. & Joober, R. (2003) Dopamine genes and attention-deficit hyperactivity disorder: a review. J Psychiatry Neurosci 28, 2738.
  • Ding, Y.C., Chi, H.C., Grady, D.L., Morishima, A., Kidd, J.R., Kidd, K.K., Flodman, P., Spence, M.A., Schuck, S., Swanson, J.M., Zhang, Y.P. & Moyzis, R.K. (2002) Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci USA 99, 309314.
  • Dougherty, D.D., Bonab, A.A., Spencer, T.J., Rauch, S.L., Madras, B.K. & Fischman, A.J. (1999) Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354, 21322133.
  • Duan, J., Wainwright, M.S., Comeron, J.M., Saitou, N., Sanders, A.R., Gelernter, J. & Gejman, P.V. (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12, 205216.
  • Dubois, B. & Pillon, B. (1997) Cognitive deficits in Parkinson's disease. J Neurol 244, 28.
  • Duman, R.S., Heninger, G.R. & Nestler, E.J. (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54, 597606.
  • D'Souza, U.M., Russ, C., Tahir, E., Mill, J., McGuffin, P., Asherson, P.J. & Craig, I.W. (2004) Functional Effects of a Tandem Duplication Polymorphism in the 5′ Flanking Region of the DRD4 Gene. Biol Psychiatry 56, 691697.
  • Egan, M.F., Goldberg, T.E., Kolachana, B.S., Callicott, J.H., Mazzanti, C.M., Straub, R.E., Goldman, D. & Weinberger, D.R. (2001) Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98, 69176922.
  • Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B. & Weinberger, D.R. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257269.
  • Egan, M.F., Straub, R.E., Goldberg, T.E., Yakub, I., Callicott, J.H., Hariri, A.R., Mattay, V.S., Bertolino, A., Hyde, T.M., Shannon-Weickert, C., Akil, M., Crook, J., Vakkalanka, R.K., Balkissoon, R., Gibbs, R.A., Kleinman, J.E. & Weinberger, D.R. (2004) Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA 101, 1260412609.
  • Eisenberg, J., Mei-Tal, G., Steinberg, A., Tartakovsky, E., Zohar, A., Gritsenko, I., Nemanov, L. & Ebstein, R.P. (1999) Haplotype relative risk study of catechol-o-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD). Am J Med Genet 88, 497502.
  • El-Ghundi, M., Fletcher, P.J., Drago, J., Sibley, D.R., O'Dowd, B.F., George, S.R. (1999) Spatial learning deficit in dopamine D (1) receptor knockout mice. Eur J Pharmacol 27, 95106.
  • Foltynie, T., Goldberg, T.E., Lewis, S.G.J., Blackwell, A.D., Kolachana, B.S., Weinberger, D.R., Robbins, T.W. & Barker, R.A. (2004) Planning ability in parkinson's disease is influenced by the COMT Val158Met polymorphism. Mov Disord 19, 885891.
  • Foltynie, T., Lewis, S.G.J., Goldberg, T.E., Blackwell, A.D., Kolachana, B.S., Weinberger, D.R., Robbins, T.W. & Barker, R.A. (in press) The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. J Neurol.
  • Fossella, J., Sommer, T., Fan, J., Wu, Y., Swanson, J.M., Pfaff, D.W. & Posner, M.I. (2002) Assessing the molecular genetics of attention networks. BMC Neurosci 3, 1425.
  • De Frias, C.M., Annerbrink, K., Westberg, L., Eriksson, E., Adolfsson, R. & Nilsson, L.G. (2004) COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet 34, 533539.
  • Gallinat, J., Bajbouj, M., Sander, T., Sclattmann, P., Xu, K., Ferro, E.F., Goldman, D. & Winterer, G. (2003) Association of the G1947A COMT (Val158Met) gene polymorphism with prefronal P300 during information processing. Biol Psychiatry 54, 4048.
  • Glahn, D.C., Bearden, C.E., Niendam, T.A. & Escamilla, M.A. (2004) The feasibility of neuropsychological endopenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 6, 171118.
  • Glatt, C.E. & Freimer, N.B. (2002) Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. Trends Genet 18, 307313.
  • Goldman-Rakic, P.S. (1995) Cellular basis of working memory. Neuron 14, 477485.
  • Goldberg, T.E. & Weinberger, D.R. (2004) Genes and the parsing of cognitive processes. Trends Cogn Sci 8, 325335.
  • Goldberg, T.E., Egan, M.F., Gscheidle, T., Coppola, R., Weickert, T., Kolachana, B.S., Goldman, D. & Weinberger, D.R. (2003) Executive subprocesses in working memory. Arch Gen Psychiatry 60, 889896.
  • Hariri, A.R., Goldberg, T.E., Mattay, V.S., Kolachana, B.S., Callicott, J.H., Egan, M.F. & Weinberger, D.R. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23, 66906694.
  • Hirvonen, M., Laakso, A., Nagren, K., Rinne, J.O., Pohjalainen, T. & Hietala, J. (2004) C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 9, 10601061.
  • Ho, B.C., Wassink, T.H., O'Leary, D.S., Sheffield, V.C. & Andreasen, N.C. (in press) Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 10, 229235.
  • Hoff, A.L. & Kremen, W.S. (2003) Neuropsychology in schizophrenia: an update. Curr Opin Psychiatry 16, 149155.
  • Horger, B.A., Iyasere, C.A., Berhow, M.T., Messer, C.J., Nestler, E.J. & Taylor, J.R. (1999) Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 19, 41104122.
  • Hung, H.C. & Lee, E.H. (1996) The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF expression. Brain Res Mol Brain Res 41, 1426.
  • Hyman, C., Juhasz, M., Jackson, C., Wright, P., Ip, N.Y. & Lindsay, R.M. (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 14, 335347.
  • Illi, A., Mattila, K.M., Kampman, O., Anttila, S., Roivas, M., Lehtimaki, T. & Leinonen, E. (2003) Catechol-O-methyltransferase and monoamine oxidase a genotypes and drug response to conventional neuroleptics in schizophrenia. J Clin Psychopharmacol 23, 429434.
  • Inada, T., Nakamura, A. & Iijima, Y. (2003) Relationship between catechol-o-methyltransferase polymorphism and treatment-resistant schizophrenia. Am J Med Genet 120B, 3539.
  • Jiang, X., Xu, K., Hoberman, J., Tian, F., Marko, A.J., Waheed, J.F., Harris, C.R., Marinia, A.M., Enoch, M.A. & Lipsky, R.H. (in press) BDNF variation and mood disorders: a novel functional promoter ploymorphism and val66met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30, 13531361.
  • Johnson, M.H. (1997) Developmental Cognitive Neuroscience. Blackwell, Oxford.
  • Joober, R., Gauthier, J., Lal, S., Bloom, D., Lalonde, P., Rouleau, G., Benkelfat, C. & Labelle, A. (2002) Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the wisconsin card sorting task. Arch General Psychiatry 59, 662663.
  • Jung, R.E., Yeo, R.A., Chiulli, S.J., Sibbitt, W.L. & Jr Brooks, , W.M. (2000) Myths of neuropsychology: intelligence, neurometabolism, and cognitive ability. Clin Neuropsychol 14, 535545.
  • Kimberg, D.Y., D'Esposito, M. & Farah, M.J. (1997) Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8, 35813585.
  • Kodoma, T., Hikosaka, K. & Watanabe, M. (1997) Differential changes in glutamate concentration in the primate prefrontal cortex during delayed spatial alteration and sensory-guided tasks. Exp Brain Res 145, 133141.
  • Kotecha, S.A., Oak, J.N., Jackson, M.F., Perez, Y., Orser, B.A., Van Tol, H.H. & MacDonald, J.F. (2002) A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35, 11111122.
  • Kustanovich, V., Ishii, J., Crawford, L., Yang, M., McGough, J.J., McCracken, J.T., Smalley, S.L. & Nelson, S.F. (2004) Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry 9, 711717.
  • Lange, K.W., Loschmann, P.A., Wachtel, H., Horowski, R., Jahnig, P., Jenner, P. & Marsden, C.D. (1992) Terguride stimulates locomotor activity at 2 months but not 10 months after 1-Methyl-4-phyl-2, 3, 6-tetrahydropyridine treatment of common marmosets. Eur J Pharmacol 212, 247252.
  • Langley, K., Marshall, L., Van Den Bree, M., Thomas, H., Owen, M., O'Donovan, M. & Thapar, A. (2004) Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry 161, 133138.
  • Lena, S.M., Fiocco, A.J. & Leyenaar, J.K. (2004) The role of cognitive deficits in the development of eating disorders. Neuropsychol Rev 14, 99113.
  • Lezak, M.D. (1995) Neuropsychological Assessment. Oxford University Press, New York.
  • Lidow, M.S., Goldman-Rakic, P.S., Gallagher, D.W. & Rakic, P. (1991) Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]spiperone and [3H]SCH23390. Neuroscience 40, 657671.
  • Luciana, M., Collins, P.F. & Depue, R.A. (1998) Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cereb Cortex 8, 218226.
  • Luciano, M., Wright, M.J., Smith, G.A., Geffen, G.M., Geffen, L.B. & Martin, N.G. (2001) Genetic covariance among measures of information processing speed, working memory, and IQ. Behav Genet 31, 581592.
  • Malhotra, A.K., Kestler, L.J., Mazzanti, C., Bates, J.A., Goldberg, T. & Goldman, D. (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159, 652654.
  • Mamounas, L.A., Blue, M.E., Siuciak, J.A. & Altar, C.A. (1995) Brain derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in the rat brain. J Neurosci 15, 79297939.
  • Manor, I., Tyano, S., Eisenberg, J., Bachner-Melman, R., Kotler, M. & Ebstein, R.P. (2002) The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance task (TOVA). Mol Psychiatry 7, 790794.
  • Mattay, V.S., Callicott, J.H., Bertolino, A., Heaton, I., Frank, J.A., Coppola, R., Berman, K.F., Goldberg, T.E. & Weinberger, D.R. (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 12, 268275.
  • Mattay, V.S., Tessitore, A., Callicott, J.H., Bertolino, A., Goldberg, T.E., Chase, T.N., Hyde, T.M., Weinberger, D.R. (2002) Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51, 156174.
  • Mattay, V.S., Goldberg, T.E., Fera, F., Hariri, A.R., Tessitore, A., Egan, M.F., Kolachana, B., Callicott, J.H. & Weinberger, D.R. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100, 61866191.
  • Mehta, M.A., Sahakian, B.J., McKenna, P.J. & Robbins, T.W. (1999) Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology 146, 162174.
  • Mehta, M.A., Manes, F.F., Magnolfi, G., Sahakian, B.J. & Robbins, T.W. (2004) Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology 176, 331342.
  • Mills, S., Langley, K., Van den Bree, M., Street, E., Turic, D., Owen, M.J., O'Donovan, M.C. & Thapar, A. (2004) No evidence of association between Catechol-O-methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: a case-control study. BMC Psychiatry 4, 1520.
  • Minichiello, L., Korte, M., Wolfer, D., Kuhn, R., Unsicker, K., Cestari, M.V., Rossi-Arnaud, C., Lipp, H.P., Bonhoeffer, T. & Klein, R. (1999) Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24, 401414.
  • Monarch, E.S., Saykin, A.J. & Flashman, L.A. (2004) Neuropsychological impairment in borderline personality disorder. Psychiatr Clin North Am 27, 6782.
  • Mossner, R., Daniel, S., Albert, D., Heils, A., Okladnova, O., Schmitt, A. & Lesch, K.P. (2000) Serotonin transporter function is modulated by brain derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 36, 197202.
  • Mu, J.S., Li, W.P., Yao, Z.B. & Zhou, X.F. (1999) Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res 835, 259265.
  • Muller, U., Von Cramon, D.Y. & Pollmann, S. (1998) D1 versus D2 receptor modulation of visuospatial working memory in humans. J Neurosci 18, 27202728.
  • Nacmias, B., Piccini, C., Bagnoli, S., Tedde, A., Cellini, E., Bracco, L. & Sorbi, S. (2004) Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett 367, 379383.
  • Narita, M., Aoki, K., Takagi, M., Yajima, Y. & Suzuki, T. (2003) Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by amphetamine. Neuroscience 119, 767775.
  • Nestler, E.J., Barrot, M., DiLeone, R.J., Eisch, A.J., Gold, S.J. & Monteggia, L.M. (2002) Neurobiology of depression. Neuron 34, 1325.
  • Noble, E.P., Berman, S.M., Ozkaragoz, T.Z. & Ritchie, T. (1994) Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. Am J Hum Genet 54, 658668.
  • Noble, E.P. (2000) The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 1, 309333.
  • Nolan, K.A., Bilder, R.M., Lachman, H.M. & Volavka, J. (2004) Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of val and met alleles on cognitive stability and flexibility. Am J Psychiatry 161, 359361.
  • Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., Iyo, M., Tateno, Y., Toru, M. (1997) Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385, 634636.
  • Okuyama, Y., Ishiguro, H., Toru, M. & Arinami, T. (1999) A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 258, 292295.
  • Ollat, H. (1992) Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil. J Neurol 239, S13S16.
  • Pang, P.T. & Lu, B. (2004) Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF. Ageing Res Rev 3, 407430.
  • Panksepp, J. (1998) Affective Neuroscience: The Foundations of Human and Animal Emotions. Oxford University Press, New York.
  • Peretti, C.S., Gierski, F. & Harrois, S. (2004) Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil. Psychopharmacology 17, 175181.
  • Petrill, S.A., Plomin, R.A., McClearn, G.E., Smith, D.L., Vignetti, S., Chorney, M.J., Chorney, K., Thompson, L.A., Detterman, D.K., Benbow, C., Lubinski, D., Daniels, J., Owen, M. & McGuffin, P. (1997) No association between general cognitive ability and the A1 allele of the D2 dopamine receptor gene. Behav Genet 27, 2931.
  • Pezawas, L., Verchinski, B.A., Mattay, V.S., Callicott, J.H., Kolachana, B.S., Straub, R.E., Egan, M.F., Meyer-Lindenberg, A. & Weinberger, D.R. (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24, 1009910102.
  • Plotkin, H. (1997) Evolution in Mind: An Introduction to Evolutionary Psychology. Penguin, London.
  • Pohjalainen T., Rinne J.O., Nagren K., Lehikoinen P., Anttila K., Syvalahti E.K., Hietala J. (1998) The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3, 256260.
  • Poo, M. (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2, 2432.
  • Pozzo-Miller, L.D., Gottschalk, W., Zhang, L., Du McDermott, K.J., Gopalakrishnan, R., Oho, C., Sheng, Z. & Lu, B. (1999) Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci 19, 49724983.
  • Previc, F.H. (1999) Dopamine and the origins of human intelligence. Brain Cogn 41, 299350.
  • Remy, P. & Samson, Y. (2003) The role of dopamine in cognition: evidence from functional imaging studies. Curr Opin Neurol 16, S37S41.
  • Rilling, J.K. & Insel, T.R. (1999) The primate neocortex in comparative perspective using magnetic resonance imaging. J Hum Evol 37, 191223.
  • Rogers, G., Joyce, P., Mulder, R., Sellman, D., Miller, A., Allington, M., Olds, R., Wells, E., Kennedy, M. (2004) Association of a duplicated repeat polymorphism in the 5′ untranslated region of the DRD4 gene with novelty seeking. Am J Med Genet 126B, 9598.
  • Rosa, A., Peralta, V., Cuesta, M.J., Zarzuela, A., Serrano, F., Martinez-Larrea, A. & Fananas, L. (2004) New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161, 11101112.
  • Rybakowski, J.K., Borkowska, A., Czerski, P.M., Skibinska, M. & Hauser, J. (2003) Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5, 468472.
  • Savitz, J.B. & Ramesar, R.S. (2004) Genetic variants implicated in personality: a review of the more promising candidates. Am J Med Genet 131B, 2032.
  • Savitz, J., Solms, M. & Ramesar, R. (2005) Neuropsychological dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disord 7, 216235.
  • Segalowitz, S.J. & Davies, P.L. (2004) Charting the maturation of the frontal lobe: an electrophysiological strategy. Brain Cogn 55, 116133.
  • Shin, M.S., Park, S.J., Kim, M.S., Lee, Y.H., Ha, T.H. & Kwon, J.S. (2004) Deficits of organisational strategy and visual memory in obsessive compulsive disorder. Neuropsychology 18, 665672.
  • Siuciak, J.A., Boylan, C., Fritsche, M., Altar, C.A. & Lindsay, R.M. (1996) BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 710, 1120.
  • Spearman, C. (1904) General intelligence, objectively determined and measured. Am J Psychol 15, 201293.
  • Stefanis, N.C., Van Os, J., Avramopolous, D., Smynis, N., Evdokimidis, I., Hantoumi, I. & Stefanis, C.N. (2004) Variation in catechol-O-methyltransferase val158met genotype associated with schizotypy but not cognition: a population study in 543 young men. Biol Psychiatry 56, 510515.
  • Stern, Y. & Langston, J.W. (1985) Intellectual changes in patient with MPTP-induced parkinsonism. Neurology 35, 15061509.
  • Strauss, J., Barr, C.L., George, C.J., Ryan, C.M., King, N., Shaikh, S. & Kennedy, J.L. (2004) BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorder. Neuromolecular Med 5, 181192.
  • Swanson, J.M., Oosterlaan, J., Murias, M. et al. (2000) ADHD children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behaviour but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci USA 97, 47544759.
  • Szeszko, P.R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., Ashtari, M., Napolitano, B., Bilder, R.M., Kane, J.M., Goldman, D. & Malhotra, A.K. (in press) Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry.
  • Taerk, E., Grizenko, N., Ben Amor, L., Lageix, P., Mbekou, V., Deguzman, R., Torkaman-Zehi, A., Ter Stepanian, M., Baron, C. & Joober, R. (2004) Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. BMC Med Genet 5, 3038.
  • Tsai, S.J., Yu Y.W.Y., Lin, C., Chen, T., Chen, S. & Hong, C. (2002) Dopamine D2 receptor and N-methyl-D-aspartate receptor 2B subunit genetic variants and intelligence. Neuropsychobiology 45, 128130.
  • Tsai, S.J., Yu, Y.W.Y., Chen, T.J., Chen, J.Y., Liou, Y.J., Chen, M.C. & Hong, C.J. (2003) Association study of a functional catechol-O-methyltransferase gene polymorphism and cognitive function in healthy females. Neurosci Lett 338, 123126.
  • Tsai, S.J., Hong, C.J., Liao, D.L., Lai, I.C. & Liou, Y.J. (2004a) Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia. Neuropsychobiology 49, 196200.
  • Tsai, S.J., Hong, C.J., Yu, Y.W.Y. & Chen, T.J. (2004b) Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 49, 1316.
  • Wang, X., Zhong, P. & Yan, Z. (2002) Dopamine D4 receptors modulate GABAergic signalling in pyramidal neurons of the prefrontal cortex. J Neurosci 22, 91859193.
  • Weickert, T.W., Goldberg, T.E., Mishara, A., Apud, J.A., Kolachana, B.S., Egan, M.F. & Weinberger, D.R. (2004) Catechol-O-methyltransferase Val108/158Met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 56, 677682.
  • Weinberger, D.R., Egan, M.F., Bertolino, A., Callicott, J.H., Mattay, V.S., Lipska, B.K., Berman, K.F. & Goldberg, T.E. (2001) Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50, 825844.
  • Welsh, M.C., Pennington, B.F. & Groisser, D.B. (1991) A normative developmental study of executive function: a window on prefrontal function in children. Dev Neuropsychol 7, 131149.
  • Winterer, G. & Weinberger, D.R. (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27, 683690.